María Soledad Undurraga
María Soledad Undurraga publishes mostly in Hematology, Genetics and Molecular Biology, on topics such as Acute Myeloid Leukemia Research, Retinoids in leukemia and cellular processes and Acute Lymphoblastic Leukemia research.
- World rank
- #2,830,332 of 7,710,434 ranked researchers
- Rank in Chile
- #5,900 of 20,642
- Works
- 22
- Citations
- 940
- Citations per work
- 42.7
What does María Soledad Undurraga research?
María Soledad Undurraga's work is mostly in Medicine (69%), Biochemistry, Genetics and Molecular Biology (12%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1568.9%
- Medicine1568.9%
- Everything else419.6%
- Life Sciences311.5%
- 1Hematology36% of their works
- 2Genetics15% of their works
- 3Molecular Biology12% of their works
- 4Public Health, Environmental and Occupational Health10% of their works
- 5Pathology and Forensic Medicine5% of their works
- 6Dermatology3% of their works
Research topics
- Acute Myeloid Leukemia Research
- Retinoids in leukemia and cellular processes
- Acute Lymphoblastic Leukemia research
- Chronic Myeloid Leukemia Treatments
- Chronic Lymphocytic Leukemia Research
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Multiple Myeloma Research and Treatments
- Lymphoma Diagnosis and Treatment
Which keywords describe María Soledad Undurraga's research?
The keywords of their largest research topics: Prognostic Factors, Acute Myeloid Leukemia, AML, Minimal Residual Disease, Acute Promyelocytic Leukemia, Retinoic Acid, Rituximab and Acute Lymphoblastic Leukemia.
- Classification
- JAK2 Mutation
- Genomic Aberrations
- Chronic Lymphocytic Leukemia
- BCR-ABL
- Acute Lymphoblastic Leukemia
- Retinoic Acid
- Minimal Residual Disease
- AML
- Prognostic Factors
- Acute Myeloid Leukemia
- Acute Promyelocytic Leukemia
- Rituximab
- Childhood Cancer
- Imatinib
- Diagnosis Criteria
- International Myeloma Working Group
- Myelofibrosis
- Lymphoma
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 19 words, with their numbers
- Prognostic Factors233 topics
- AML131 topic
- Acute Myeloid Leukemia131 topic
- Minimal Residual Disease102 topics
- Acute Promyelocytic Leukemia71 topic
- Retinoic Acid71 topic
- Rituximab72 topics
- Acute Lymphoblastic Leukemia61 topic
- Childhood Cancer61 topic
- BCR-ABL51 topic
- Imatinib51 topic
- Chronic Lymphocytic Leukemia41 topic
- Diagnosis Criteria41 topic
- Genomic Aberrations41 topic
- International Myeloma Working Group41 topic
- JAK2 Mutation41 topic
- Myelofibrosis41 topic
- Classification31 topic
- Lymphoma31 topic
Where does María Soledad Undurraga work?
María Soledad Undurraga's main affiliation in the publication record is Hospital del Salvador, Chile.
How many publications and citations does María Soledad Undurraga have?
OpenAlex counts 22 works and 940 citations for María Soledad Undurraga, an h-index of 6, ranking #2,830,332 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about María Soledad Undurraga. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.